A case of extensive alopecia areata following Pfizer‐BioNTech BNT162b2 mRNA COVID‐19 vaccine with favorable outcome
A 37‐year‐old woman developed persistent low‐grade fever (37.2°C) on day +13 after the first dose of BNT162b2 mRNA vaccine. She noticed coin‐sized hair loss on day +22, and it became widespread within 1 week. The patient's hair mostly recovered leaving only one oval bald patch on day +310 with...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-06-01
|
Series: | Journal of Cutaneous Immunology and Allergy |
Online Access: | https://doi.org/10.1002/cia2.12292 |